Aegis Capital Corp. Acted as Sole Bookrunner on a $12 Million Underwritten Public Offering for Avenue Therapeutics, Inc.

NEW YORK, NY / ACCESSWIRE / October 12, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $12 Million Underwritten Public Offering for Avenue Therapeutics, Inc. (NASDAQ:ATXI).About Avenue Therapeutics

Related Keywords

New York ,United States , ,Investment Banking Services ,Aegis Capital Corporation ,Nasdaq ,Avenue Therapeutics Inc ,Million Underwritten Public Therapeutics Inc ,Therapeutics Inc ,Aegis Capital Corp ,Aegis Capital ,Sole Bookrunner ,Underwritten Public Offering ,Avenue Therapeutics ,Fortress Biotech Specialty Pharmaceutical ,Capital Corporation ,Capital Corp ,Aegis ,Capital ,Orp ,Hcted ,Sole ,Bookrunner ,Billion ,Underwritten ,Public ,Offering ,Revenue ,Herapeutics ,